Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier

被引:21
作者
Matsui, Hideki [1 ]
Sato, Yusuke [1 ]
Hatakeyama, Hiroto [1 ]
Akita, Hidetaka [1 ]
Harashima, Hideyoshi [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
关键词
Peritoneal macrophages; Short interference RNA; pH-Sensitive cationic lipid; Multifunctional envelope-type nano device; Size; Administration route; DOUBLE-STRANDED-RNA; ENHANCED HEPATIC-UPTAKE; SMALL INTERFERING RNA; COMPLEMENT ACTIVATION; LIPID NANOPARTICLES; DELIVERY; ALPHA; THERAPEUTICS;
D O I
10.1016/j.ijpharm.2015.08.044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Macrophages are key contributors to various inflammatory diseases. Therefore, the development of an efficient in vivo short interference RNA (siRNA) system that can be delivered to macrophages represents a novel treatment strategy for addressing these disorders. It was recently revealed that peritoneal macrophages (PEMs) are involved in several diseases including ovarian cancer, and are now recognized as a promising drug target. We report herein on the use of pH-sensitive cationic YSK05-MENDs as siRNA carriers and on the impact of both the size of the YSK05-MENDs and their administration routes for the efficient targeting PEMs to achieve a high level of gene silencing activity. The size of the YSK05-MENDs had a dramatic effect on their specificity for PEMs when administered intravenously, but not for intraperitoneal injection. Also, significant gene silencing was achieved by an intraperitoneal administration of the YSK05-MEND at a dose in the single digit mg/kg range. To our knowledge, this is the most efficacious method for siRNA delivery for gene silencing in PEMs in vivo reported to date. These findings enabled us to investigate the complex function of PEMs through several gene silencing simultaneously. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 36 条
[1]   Two physically, functionally, and developmentally distinct peritoneal macrophage subsets [J].
Bou Ghosn, Eliver Eid ;
Cassado, Alexandra A. ;
Govoni, Gregory R. ;
Fukuhara, Takeshi ;
Yang, Yang ;
Monack, Denise M. ;
Bortoluci, Karina R. ;
Almeida, Sandro R. ;
Herzenberg, Leonard A. ;
Herzenberg, Leonore A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (06) :2568-2573
[2]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140
[3]   Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays [J].
Der, SD ;
Zhou, AM ;
Williams, BRG ;
Silverman, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15623-15628
[4]   Phagocytosis: latex leads the way [J].
Desjardins, M ;
Griffiths, G .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (04) :498-503
[5]   Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J].
Fire, A ;
Xu, SQ ;
Montgomery, MK ;
Kostas, SA ;
Driver, SE ;
Mello, CC .
NATURE, 1998, 391 (6669) :806-811
[6]   A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling [J].
Geiss, G ;
Jin, G ;
Guo, JJ ;
Bumgarner, R ;
Katze, MG ;
Sen, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30178-30182
[7]   ENHANCED HEPATIC-UPTAKE OF LIPOSOMES THROUGH COMPLEMENT ACTIVATION DEPENDING ON THE SIZE OF LIPOSOMES [J].
HARASHIMA, H ;
SAKATA, K ;
FUNATO, K ;
KIWADA, H .
PHARMACEUTICAL RESEARCH, 1994, 11 (03) :402-406
[8]   Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats [J].
Harashima, H ;
Huong, TM ;
Ishida, T ;
Manabe, Y ;
Matsuo, H ;
Kiwada, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (11) :1704-1709
[9]   The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice [J].
Hatakeyama, Hiroto ;
Murata, Manami ;
Sato, Yusuke ;
Takahashi, Mayumi ;
Minakawa, Noriaki ;
Matsuda, Akira ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2014, 173 :43-50
[10]   Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes [J].
Hayashi, Yasuhiro ;
Suemitsu, Erina ;
Kajimoto, Kazuaki ;
Sato, Yusuke ;
Akhter, Afsana ;
Sakurai, Yu ;
Hatakeyama, Hiroto ;
Hyodo, Mamoru ;
Kaji, Noritada ;
Baba, Yoshinobu ;
Harashima, Hideyoshi .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 :e154